AbbVie is experiencing increased momentum as analysts raise targets, positioning the stock near its 52-week high amidst strong technical indicators and favorable market sentiment.

Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.

The CPI report for October may be cancelled.

The Euro eases to 1.1575 but remains trading within the previous day's range.

President Trump proposed, with the full support of Federal Housing Director Bill Pulte, that homeowners be allowed to take out 50-year mortgages.

A review and analysis of the precious metals markets.